Shatin D - Search Results

1

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R. Graham DJ, et al. Among authors: shatin d. JAMA. 2004 Dec 1;292(21):2585-90. doi: 10.1001/jama.292.21.2585. Epub 2004 Nov 22. JAMA. 2004. PMID: 15572716

2

Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.

Graham DJ, Drinkard CR, Shatin D. Graham DJ, et al. Among authors: shatin d. Am J Gastroenterol. 2003 Jan;98(1):175-9. doi: 10.1111/j.1572-0241.2003.07175.x. Am J Gastroenterol. 2003. PMID: 12526954

3

Risk factors for statin-associated rhabdomyolysis.

Schech S, Graham D, Staffa J, Andrade SE, La Grenade L, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D. Schech S, et al. Among authors: shatin d. Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):352-8. doi: 10.1002/pds.1287. Pharmacoepidemiol Drug Saf. 2007. PMID: 16892458

4

Liver enzyme monitoring in patients treated with troglitazone.

Graham DJ, Drinkard CR, Shatin D, Tsong Y, Burgess MJ. Graham DJ, et al. Among authors: shatin d. JAMA. 2001 Aug 15;286(7):831-3. doi: 10.1001/jama.286.7.831. JAMA. 2001. PMID: 11497537

5

Contraindicated use of cisapride: impact of food and drug administration regulatory action.

Smalley W, Shatin D, Wysowski DK, Gurwitz J, Andrade SE, Goodman M, Chan KA, Platt R, Schech SD, Ray WA. Smalley W, et al. Among authors: shatin d. JAMA. 2000 Dec 20;284(23):3036-9. doi: 10.1001/jama.284.23.3036. JAMA. 2000. PMID: 11122591

6

A study of compliance with FDA recommendations for pemoline (Cylert).

Willy ME, Manda B, Shatin D, Drinkard CR, Graham DJ. Willy ME, et al. Among authors: shatin d. J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):785-90. doi: 10.1097/00004583-200207000-00009. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 12108802

7

Ambulatory use of ticlopidine and clopidogrel in association with percutaneous coronary revascularization procedures in a national managed care organization.

Shatin D, Schech SD, Brinker A. Shatin D, et al. J Interv Cardiol. 2002 Jun;15(3):181-6. doi: 10.1111/j.1540-8183.2002.tb01053.x. J Interv Cardiol. 2002. PMID: 12141141

8

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis.

Andrade SE, Graham DJ, Staffa JA, Schech SD, Shatin D, La Grenade L, Goodman MJ, Platt R, Gurwitz JH, Chan KA. Andrade SE, et al. Among authors: shatin d. J Clin Epidemiol. 2005 Feb;58(2):171-4. doi: 10.1016/j.jclinepi.2004.10.004. J Clin Epidemiol. 2005. PMID: 15680751

9

New-onset and idiopathic thrombotic thrombocytopenic purpura: incidence, diagnostic validity, and potential risk factors.

Schech SD, Brinker A, Shatin D, Burgess M. Schech SD, et al. Among authors: shatin d. Am J Hematol. 2006 Sep;81(9):657-63. doi: 10.1002/ajh.20669. Am J Hematol. 2006. PMID: 16795056 Free article.

10

Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.

Chang S, Begier EM, Schech SD, Venus P, Shatin D, Braun MM, Ball R. Chang S, et al. Among authors: shatin d. Pediatr Infect Dis J. 2007 Apr;26(4):329-33. doi: 10.1097/01.inf.0000258616.12752.51. Pediatr Infect Dis J. 2007. PMID: 17414397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page